17.25 +0.70 (4.23%)
Pre-market: 4:20AM EST
|Bid||16.70 x 100|
|Ask||18.55 x 500|
|Day's range||13.73 - 16.77|
|52-week range||8.21 - 23.01|
|PE ratio (TTM)||30.59|
|Earnings date||8 Feb 2018 - 9 Feb 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||19.60|
Orasure Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83.
Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.
After the completion of Shiel's acquisition, the medical lab is expected to expand Quest Diagnostics' (DGX) physician and patient service centers network in the New York-New Jersey area.